Redeye retains its positive view of CombinedX following the Q3 report. While EBIT came short of our expectations, largely due to higher Other external costs, the per-employee and working day data and the market outlook were positive. CombinedX grew by 8% organically, outgrowing most peers in the softening market.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

CombinedX - Positive Market Outlook

© Modular Finance, source Nordic Press Releases